Systematic Reviews
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Aug 26, 2017; 5(4): 103-123
Published online Aug 26, 2017. doi: 10.13105/wjma.v5.i4.103
Medication non-adherence in bipolar disorder: Review of rates, demographic and clinical predictors
Subho Chakrabarti
Subho Chakrabarti, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
Author contributions: Chakrabarti S solely contributed to this paper.
Conflict-of-interest statement: No conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Subho Chakrabarti, MD, FAMS, FRCPsych, Professor, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. subho@pgimer.edu.in
Telephone: +91-172-2756808 Fax: +91-172-2744401
Received: February 28, 2017
Peer-review started: March 2, 2017
First decision: April 18, 2017
Revised: May 31, 2017
Accepted: June 12, 2017
Article in press: June 13, 2017
Published online: August 26, 2017
Processing time: 176 Days and 2.3 Hours
Abstract
AIM

To conduct a systematic search for all studies examining rates and demographic and illness-related determinants of medication non-adherence in bipolar disorder (BD).

METHODS

A comprehensive literature search was undertaken of six English-language databases to identify published articles on medication non-adherence in BD from inception till December 2016. Any article, either a review or an original-research article was examined for its relevance to the subject. All such articles were manually searched to locate any further articles containing relevant information. Studies were included only if they had adequately described the patient sample, assessment methods and statistical procedures, presented their results systematically and their conclusions were congruent with the results.

RESULTS

The initial search yielded 249 articles on the subject; of these 198 articles were included. Of the 162 original-research studies, 132 had provided information on rates of medication non-adherence in BD. There was a wide variation in rates ranging from universal adherence (100%) to almost universal non-adherence (96%); this discrepancy was more due to methodological differences than true variations in rates. Notwithstanding the significant discrepancies in methodology, based on these 132 studies mean rates of 41.5%-43% and median rates of 40%-41% were obtained for medication non-adherence in BD. Rates of adherence with mood stabilizers were significantly lower than those for antipsychotics, or for medications of all classes. None of the demographic attributes were unequivocally linked to medication non-adherence in BD. Similarly, medication-related variables such as type of medications, doses, treatment regimens and side effects did not demonstrate consistent associations with non-adherence. Among clinical characteristics the presence of comorbid substance use disorder and absence of insight were the only two factors clearly linked to non-adherence in BD.

CONCLUSION

Medication non-adherence is prevalent in about a third to half of patients with BD. Demographic, illness and treatment related factors do not predict non-adherence with certainty.

Keywords: Medications; Demographics; Rates; Non-adherence; Illness characteristics; Treatment variables; Bipolar disorder

Core tip: Based on existing reviews non-adherence is estimated to be present in 25%-42% of patients with bipolar disorder (BD). The present, more comprehensive review comprising of 198 studies found mean rates of 41.5%-43% and median rates of 40%-41% for medication non-adherence in BD. Neither demographic characteristics nor medication-related variables were unequivocally linked to medication non-adherence in BD, while comorbid substance use disorder and absence of insight were the only two clinical factors consistently associated with non-adherence in BD. The failure of clinical and demographic factors to predict non-adherence emphasizes the importance of other patient orientated factors in determining non-adherence in BD.